Literature DB >> 16765180

Macronutrients, fatty acids, cholesterol, and risk of benign prostatic hyperplasia.

Francesca Bravi1, Cristina Bosetti, Luigino Dal Maso, Renato Talamini, Maurizio Montella, Eva Negri, Valerio Ramazzotti, Silvia Franceschi, Carlo La Vecchia.   

Abstract

OBJECTIVES: To better understand the role of specific macronutrients on the risk of benign prostatic hyperplasia (BPH), we used data from an Italian case-control study. Although BPH is extremely common among the elderly, its etiology-and, particularly, the role of diet and specific macronutrients-is still unclear.
METHODS: A case-control study of 1369 patients with BPH and 1451 controls, admitted to the same hospitals for a wide spectrum of acute, non-neoplastic conditions, was conducted in Italy. The subjects' usual diet was investigated through a validated and reproducible food frequency questionnaire. Multivariate odds ratios (ORs) and 95% confidence intervals (CIs) were obtained after allowance for energy intake and other potential confounding factors.
RESULTS: A significant direct relation was observed between starch intake (OR 1.51, 95% CI 1.15 to 1.99 for highest quintile compared with lowest one), and an inverse relation was observed for polyunsaturated fatty acids (OR 0.72, 95% CI 0.55 to 0.93), linoleic acid (OR 0.73, 95% CI 0.56 to 0.94), and linolenic acid (OR 0.71, 95% CI 0.54 to 0.93).
CONCLUSIONS: The results of this study suggest a role for specific macronutrients in the risk of BPH, including, in particular, an unfavorable effect for starch and a beneficial one for polyunsaturated fatty acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765180     DOI: 10.1016/j.urology.2006.01.007

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Role of complimentary therapy for male LUTS.

Authors:  Philippa J Cheetham
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

3.  Lower urinary tract symptoms and diet quality: findings from the 2000-2001 National Health and Nutrition Examination Survey.

Authors:  Bradley A Erickson; Mary Vaughan-Sarrazin; Xin Liu; Benjamin N Breyer; Karl J Kreder; Peter Cram
Journal:  Urology       Date:  2012-06       Impact factor: 2.649

4.  Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.

Authors:  Elin Thysell; Izabella Surowiec; Emma Hörnberg; Sead Crnalic; Anders Widmark; Annika I Johansson; Pär Stattin; Anders Bergh; Thomas Moritz; Henrik Antti; Pernilla Wikström
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

5.  Dietary macronutrients, cholesterol, and sodium and lower urinary tract symptoms in men.

Authors:  Nancy Nairi Maserejian; Edward L Giovannucci; John B McKinlay
Journal:  Eur Urol       Date:  2008-08-03       Impact factor: 20.096

6.  Diets rich in saturated and polyunsaturated fatty acids induce morphological alterations in the rat ventral prostate.

Authors:  Angélica Furriel; Pamella Campos-Silva; Paola Cariello Guedes Picarote Silva; Waldemar Silva Costa; Francisco José Barcellos Sampaio; Bianca Martins Gregório
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

7.  Dietary fatty acid quality affects systemic parameters and promotes prostatitis and pre-neoplastic lesions.

Authors:  Danilo Ferrucci; Silas Pinto Silva; Andr Rocha; Lucas Nascimento; André Schwambach Vieira; Sebastião Roberto Taboga; Marcelo Mori; Carlos Lenz-Cesar; Hernandes F Carvalho
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

8.  Association of Functional Ability and Benign Prostatic Hyperplasia With Urinary Incontinence in Older Korean Men.

Authors:  Jeongok Park; Gwi-Ryung Son Hong
Journal:  Int Neurourol J       Date:  2016-06-24       Impact factor: 2.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.